➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
McKinsey
Colorcon
Moodys
Dow

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

ESTROGENS, ESTERIFIED - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for estrogens, esterified and what is the scope of patent protection?

Estrogens, esterified is the generic ingredient in six branded drugs marketed by Bristol Myers Squibb, Pvt Form, Sandoz, Solvay, Roche Palo, and Monarch Pharms, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for estrogens, esterified. One supplier is listed for this compound.

Recent Clinical Trials for ESTROGENS, ESTERIFIED

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Stanley Medical Research InstitutePhase 2
The AlfredPhase 2
Solvay PharmaceuticalsPhase 2

See all ESTROGENS, ESTERIFIED clinical trials

US Patents and Regulatory Information for ESTROGENS, ESTERIFIED

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pvt Form ESTERIFIED ESTROGENS estrogens, esterified TABLET;ORAL 083414-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Roche Palo EVEX estrogens, esterified TABLET;ORAL 084215-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pvt Form ESTERIFIED ESTROGENS estrogens, esterified TABLET;ORAL 085907-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pvt Form FEMOGEN estrogens, esterified TABLET;ORAL 085007-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Solvay ESTRATAB estrogens, esterified TABLET;ORAL 083209-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Monarch Pharms MENEST estrogens, esterified TABLET;ORAL 084950-001 Approved Prior to Jan 1, 1982 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Moodys
Harvard Business School
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.